- Home
- HAIN vs LONA Comparison
HAIN vs LONA Comparison
Compare HAIN & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAIN | LONA |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | United States | United States |
| Employees | N/A | 26 |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.1M | 83.7M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | HAIN | LONA |
|---|---|---|
| Price | $0.65 | $8.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 1 |
| Target Price | $2.23 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 1.1M | 30.8K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,457,769,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.55 | $4.21 |
| 52 Week High | $3.07 | $14.21 |
Technical Indicators
Market Signals| Indicator | HAIN | LONA |
|---|---|---|
| Relative Strength Index (RSI) | 37.32 | 47.26 |
| Support Level | $0.59 | $8.00 |
| Resistance Level | $0.73 | $9.88 |
| Average True Range (ATR) | 0.10 | 0.87 |
| MACD | -0.02 | -0.20 |
| Stochastic Oscillator | 23.40 | 29.11 |
Price Performance
Historical ComparisonAbout HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
About LONA LeonaBio Inc. Common Stock
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).